MedTrace Logo

Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan

NCT03615846 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 147

Last updated 2021-09-14

No results posted yet for this study

Summary

This is a multi-center convenience sample prospective study comparing the results of the Verify Now® Aspirin Test and PRUTest® Platelet Reactivity Tests with the Japan investigational reagents to reagents registered in Japan in the expected population receiving aspirin (ASA) and the P2Y12 inhibitor clopidogrel.

Conditions

Sponsors & Collaborators

  • Accriva Diagnostics

    lead INDUSTRY

Principal Investigators

  • Marc Rubinstein, MD · Instrumentation Laboratory

  • Michael Martin · Accrira Diagnostics / Instrumentation Laboratory

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-15
Primary Completion
2021-10-30
Completion
2022-10-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03615846 on ClinicalTrials.gov